EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Antibody drug conjugates in the clinic

Edidiong Udofa iD, Disha Sankholkar, Samir Mitragotri iD, Zongmin Zhao iD

Bioengineering & Translational Medicine · 2024-11 · 9 (6)

DOI: 10.1002/btm2.10677 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Bioengineering & Translational Medicine, online erschienen am 04.05.2024. Verfasst von Edidiong Udofa und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences University of Illinois Chicago Chicago Illinois USA. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 139 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antibody‐drug conjugates (ADCs), chemotherapeutic agents conjugated to an antibody to enhance their targeted delivery to tumors, represent a significant advancement in cancer therapy. ADCs combine the precise targeting capabilities of antibodies and the potent cell‐killing effects of chemotherapy, allowing for enhanced cytotoxicity to tumors while minimizing damage to healthy tissues. Here, we provide an overview of the current clinical landscape of ADCs, highlighting 11 U.S. Food and Drug Administration (FDA)‐approved products and discussing over 500 active clinical trials investigating newer ADCs. We also discuss some key challenges associated with the clinical translation of ADCs and highlight emerging strategies to overcome these hurdles. Our discussions will provide useful guidelines for the future development of safer and more effective ADCs for a broader range of indications.

Schlagwörter

Stichwörter der Autor:innen

ADCFDAantibodyantibody–drug conjugatecancercancer treatmentchemotherapyclinicclinical translationclinical trialdrug delivery

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences University of Illinois Chicago Chicago Illinois USA.
  • University of Michigan Ann Arbor Ann Arbor Michigan USA.
  • John A. Paulson School of Engineering and Applied Sciences Harvard University Cambridge Massachusetts USA.
  • Wyss Institute for Biologically Inspired Engineering at Harvard University Boston Massachusetts USA.
  • University of Illinois Cancer Center Chicago Illinois USA.

ORCID-Profile: Edidiong Udofa, Samir Mitragotri, Zongmin Zhao

Zitieren

APA

Udofa, E., Sankholkar, D., Mitragotri, S., & Zhao, Z. (2024). Antibody drug conjugates in the clinic. Bioengineering & Translational Medicine, 9(6). https://doi.org/10.1002/btm2.10677

Vancouver

Udofa E, Sankholkar D, Mitragotri S, Zhao Z. Antibody drug conjugates in the clinic. Bioengineering & Translational Medicine. 2024;9(6). doi:10.1002/btm2.10677

BibTeX
@article{Udofa2024,
  author = {Udofa, Edidiong and Sankholkar, Disha and Mitragotri, Samir and Zhao, Zongmin},
  title = {Antibody drug conjugates in the clinic},
  journal = {Bioengineering & Translational Medicine},
  year = {2024},
  volume = {9},
  number = {6},
  doi = {10.1002/btm2.10677}
}
Kostenlos starten →